Cell Surface-localized Matrix Metalloproteinase-9 Proteolytically Activates TGF-beta and Promotes Tumor Invasion and Angiogenesis

Overview

Journal Genes Dev

Specialty Molecular Biology

Date 2000 Feb 1

PMID 10652271

Citations 767

Authors

Q Yu

I Stamenkovic

Affiliations

Soon will be listed here.

Abstract

We have uncovered a novel functional relationship between the hyaluronan receptor CD44, the matrix metalloproteinase-9 (MMP-9) and the multifunctional cytokine TGF-beta in the control of tumor-associated tissue remodeling. CD44 provides a cell surface docking receptor for proteolytically active MMP-9 and we show here that localization of MMP-9 to cell surface is required for its ability to promote tumor invasion and angiogenesis. Our observations also indicate that MMP-9, as well as MMP-2, proteolytically cleaves latent TGF-beta, providing a novel and potentially important mechanism for TGF-beta activation. In addition, we show that MMP-9 localization to the surface of normal keratinocytes is CD44 dependent and can activate latent TGF-beta. These observations suggest that coordinated CD44, MMP-9, and TGF-beta function may provide a physiological mechanism of tissue remodeling that can be adopted by malignant cells to promote tumor growth and invasion.

Citing Articles

LncRNA SChLAP1 promotes cancer cell proliferation and invasion via its distinct structural domains and conserved regions.

Oh M, Kadam R, Charania Z, Somarowthu S bioRxiv. 2025; .

PMID: 39975023 PMC: 11838354. DOI: 10.1101/2025.01.28.635288.

Sodium propionate decreases implant-induced foreign body response in mice.

do Carmo D, Lazari M, Dos Santos L, Costa P, Jesus I, Guatimosim S PLoS One. 2025; 20(2):e0316764.

PMID: 39970160 PMC: 11838875. DOI: 10.1371/journal.pone.0316764.

Prodomain processing controls BMP-10 bioactivity and targeting to fibrillin-1 in latent conformation.

Spanou C, Yang C, Godwin A, Morosky S, Anbalagan A, Lutke S FASEB J. 2025; 39(3):e70373.

PMID: 39921464 PMC: 11806408. DOI: 10.1096/fj.202401694R.

TGF-β induces cholesterol accumulation to regulate the secretion of tumor-derived extracellular vesicles.

Rodrigues-Junior D, Tsirigoti C, Psatha K, Kletsas D, Aivaliotis M, Heldin C J Exp Clin Cancer Res. 2025; 44(1):42.

PMID: 39910665 PMC: 11800471. DOI: 10.1186/s13046-025-03291-0.

Potential implications of granzyme B in keloids and hypertrophic scars through extracellular matrix remodeling and latent TGF-β activation.

Aubert A, Goeres J, Liu A, Kao M, Richardson K, Jung K Front Immunol. 2025; 15:1484462.

PMID: 39885984 PMC: 11779620. DOI: 10.3389/fimmu.2024.1484462.

References

Roberts A, Sporn M, Assoian R, Smith J, Roche N, Wakefield L . Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986; 83(12):4167-71. PMC: 323692. DOI: 10.1073/pnas.83.12.4167. View

Bourguignon L, Iida N, Zhu H, Young L, Muller W, Cardiff R . CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol. 1998; 176(1):206-15. DOI: 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3. View

Aruffo A, Stamenkovic I, Melnick M, Underhill C, Seed B . CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990; 61(7):1303-13. DOI: 10.1016/0092-8674(90)90694-a. View

Sato Y, Tsuboi R, Lyons R, MOSES H, Rifkin D . Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol. 1990; 111(2):757-63. PMC: 2116212. DOI: 10.1083/jcb.111.2.757. View

Moses H, Yang E, Pietenpol J . TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell. 1990; 63(2):245-7. DOI: 10.1016/0092-8674(90)90155-8. View

Welch D, Fabra A, Nakajima M . Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci U S A. 1990; 87(19):7678-82. PMC: 54811. DOI: 10.1073/pnas.87.19.7678. View

Massague J . The transforming growth factor-beta family. Annu Rev Cell Biol. 1990; 6:597-641. DOI: 10.1146/annurev.cb.06.110190.003121. View

Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I . A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 1991; 65(1):13-24. DOI: 10.1016/0092-8674(91)90403-l. View

Sy M, Guo Y, Stamenkovic I . Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med. 1991; 174(4):859-66. PMC: 2118964. DOI: 10.1084/jem.174.4.859. View

10.

Kim J, Yu W, Kovalski K, OSSOWSKI L . Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell. 1998; 94(3):353-62. DOI: 10.1016/s0092-8674(00)81478-6. View

11.

Taipale J, Saharinen J, Keski-Oja J . Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. Adv Cancer Res. 1998; 75:87-134. DOI: 10.1016/s0065-230x(08)60740-x. View

12.

Oft M, Heider K, Beug H . TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol. 1998; 8(23):1243-52. DOI: 10.1016/s0960-9822(07)00533-7. View

13.

Yu Q, Stamenkovic I . Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 1999; 13(1):35-48. PMC: 316376. DOI: 10.1101/gad.13.1.35. View

14.

Munger J, Huang X, Kawakatsu H, Griffiths M, Dalton S, Wu J . The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999; 96(3):319-28. DOI: 10.1016/s0092-8674(00)80545-0. View

15.

Li D, Sorensen L, Brooke B, Urness L, Davis E, Taylor D . Defective angiogenesis in mice lacking endoglin. Science. 1999; 284(5419):1534-7. DOI: 10.1126/science.284.5419.1534. View

16.

Sternlicht M, Lochter A, Sympson C, Huey B, Rougier J, Gray J . The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell. 1999; 98(2):137-46. PMC: 2853255. DOI: 10.1016/s0092-8674(00)81009-0. View

17.

Border W, Ruoslahti E . Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest. 1992; 90(1):1-7. PMC: 443055. DOI: 10.1172/JCI115821. View

18.

Ueki N, Nakazato M, Ohkawa T, Ikeda T, Amuro Y, Hada T . Excessive production of transforming growth-factor beta 1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth. Biochim Biophys Acta. 1992; 1137(2):189-96. DOI: 10.1016/0167-4889(92)90201-l. View

19.

Seiter S, ARCH R, Reber S, Komitowski D, Hofmann M, Ponta H . Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med. 1993; 177(2):443-55. PMC: 2190906. DOI: 10.1084/jem.177.2.443. View

20.

Roberts A, Sporn M . Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors. 1993; 8(1):1-9. DOI: 10.3109/08977199309029129. View